Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Youcef Mehellou

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
ACS Medicinal Chemistry Letters|July 19, 2023
Parkinson's Disease: Are PINK1 Activators Inching Closer to the Clinic?Youcef Mehellou
Chemmedchem|September 25, 2010
Phosphoramidate prodrugs deliver with potency against hepatitis C virusYoucef Mehellou
Chemmedchem|May 10, 2016
The ProTides BoomYoucef Mehellou
Nature|January 12, 2021
A two-pronged attack on antibiotic-resistant microbesYoucef Mehellou, Benjamin E Willcox
Journal of Medicinal Chemistry|September 30, 2009
Twenty-six years of anti-HIV drug discovery: where do we stand and where do we go?Youcef Mehellou, Erik De Clercq
Chembiochem : a European Journal of Chemical Biology|September 25, 2018
Chemical Strategies for Activating PINK1, a Protein Kinase Mutated in Parkinson's DiseaseOlivia A Lambourne, Youcef Mehellou
Chembiochem : a European Journal of Chemical Biology|October 16, 2019
The Cul4-DDB1-WDR3/WDR6 Complex Binds SPAK and OSR1 Kinases in a Phosphorylation-Dependent MannerBinar A Dhiani, Youcef Mehellou
Chemmedchem|September 18, 2009
Aryloxy phosphoramidate triesters: a technology for delivering monophosphorylated nucleosides and sugars into cellsYoucef Mehellou, Jan Balzarini, Christopher McGuigan
Organic & Biomolecular Chemistry|June 9, 2009
An investigation into the anti-HIV activity of 2',3'-didehydro-2',3'-dideoxyuridine (d4U) and 2',3'-dideoxyuridine (ddU) phosphoramidate 'ProTide' derivativesYoucef Mehellou, Jan Balzarini, Christopher McGuigan
Antiviral Chemistry & Chemotherapy|March 17, 2010
The design, synthesis and antiviral evaluation of a series of 5-trimethylsilyl-1-beta-D-(arabinofuranosyl)uracil phosphoramidate ProTidesYoucef Mehellou, Jan Balzarini, Christopher McGuigan
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
ACS Medicinal Chemistry Letters|July 19, 2023
Parkinson's Disease: Are PINK1 Activators Inching Closer to the Clinic?Youcef Mehellou
Chemmedchem|September 25, 2010
Phosphoramidate prodrugs deliver with potency against hepatitis C virusYoucef Mehellou
Chemmedchem|May 10, 2016
The ProTides BoomYoucef Mehellou
Nature|January 12, 2021
A two-pronged attack on antibiotic-resistant microbesYoucef Mehellou, Benjamin E Willcox
Journal of Medicinal Chemistry|September 30, 2009
Twenty-six years of anti-HIV drug discovery: where do we stand and where do we go?Youcef Mehellou, Erik De Clercq
Chembiochem : a European Journal of Chemical Biology|September 25, 2018
Chemical Strategies for Activating PINK1, a Protein Kinase Mutated in Parkinson's DiseaseOlivia A Lambourne, Youcef Mehellou
Chembiochem : a European Journal of Chemical Biology|October 16, 2019
The Cul4-DDB1-WDR3/WDR6 Complex Binds SPAK and OSR1 Kinases in a Phosphorylation-Dependent MannerBinar A Dhiani, Youcef Mehellou
Chemmedchem|September 18, 2009
Aryloxy phosphoramidate triesters: a technology for delivering monophosphorylated nucleosides and sugars into cellsYoucef Mehellou, Jan Balzarini, Christopher McGuigan
Organic & Biomolecular Chemistry|June 9, 2009
An investigation into the anti-HIV activity of 2',3'-didehydro-2',3'-dideoxyuridine (d4U) and 2',3'-dideoxyuridine (ddU) phosphoramidate 'ProTide' derivativesYoucef Mehellou, Jan Balzarini, Christopher McGuigan
Antiviral Chemistry & Chemotherapy|March 17, 2010
The design, synthesis and antiviral evaluation of a series of 5-trimethylsilyl-1-beta-D-(arabinofuranosyl)uracil phosphoramidate ProTidesYoucef Mehellou, Jan Balzarini, Christopher McGuigan
Pageof 5